Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
KS.1.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
KS.1.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
KS.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KS.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.1.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FL.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.1.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FL.1.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FL.1.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FL.1.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FL.1.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FY.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FY.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FY.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FY.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FY.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FY.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FY.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FY.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.466EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.466EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.466ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.466ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.466EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.466EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.466ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.466ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
L.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
L.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
L.4ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
L.4ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
L.4EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
L.4EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
L.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
L.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.339EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.339EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.339ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.339ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.339EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.339EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.339ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.339ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.229EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.229EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.229ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.229ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.229EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.229EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used